Total Funding
8
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
435039
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
William Rastetter: Co-FounderPast Role: Venrock, Partner
Raymond E. Stevens: FounderPast Role: AltheRx Pharmaceuticals, Co-founder, Vice-President of Operations
About the Company
Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.
Women Founded
